Follow
Salvatore Mazzeo
Salvatore Mazzeo
Verified email at hsr.it
Title
Cited by
Cited by
Year
From subjective cognitive decline to Alzheimer’s disease: The predictive role of neuropsychological assessment, personality traits, and cognitive reserve. A 7-year follow-up study
V Bessi, S Mazzeo, S Padiglioni, C Piccini, B Nacmias, S Sorbi, L Bracco
Journal of Alzheimer's Disease 63 (4), 1523-1535, 2018
952018
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study
S Mazzeo, S Padiglioni, S Bagnoli, L Bracco, B Nacmias, S Sorbi, V Bessi
Journal of neurology 266 (2), 487-497, 2019
652019
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
G Giacomucci, S Mazzeo, S Bagnoli, A Ingannato, D Leccese, V Berti, ...
Journal of neurology 269 (8), 4270-4280, 2022
432022
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer’s disease: a 9-year follow-up study
V Bessi, S Mazzeo, S Bagnoli, S Padiglioni, M Carraro, I Piaceri, L Bracco, ...
European Archives of Psychiatry and Clinical Neuroscience 270, 471-482, 2020
302020
Combining cerebrospinal fluid biomarkers and neuropsychological assessment: a simple and cost-effective algorithm to predict the progression from mild cognitive impairment to …
S Mazzeo, R Santangelo, MP Bernasconi, G Cecchetti, A Fiorino, P Pinto, ...
Journal of Alzheimer's Disease 54 (4), 1495-1508, 2016
292016
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: An 11‐year follow‐up study
S Mazzeo, S Padiglioni, S Bagnoli, M Carraro, I Piaceri, L Bracco, ...
European Journal of Neurology 27 (5), 894-899, 2020
192020
CHRNA7 gene and response to cholinesterase inhibitors in an Italian cohort of Alzheimer’s disease patients
F Clarelli, E Mascia, R Santangelo, S Mazzeo, G Giacalone, D Galimberti, ...
Journal of Alzheimer's Disease 52 (4), 1203-1208, 2016
192016
Gender differences in cognitive reserve: implication for subjective cognitive decline in women
G Giacomucci, S Mazzeo, S Padiglioni, S Bagnoli, L Belloni, C Ferrari, ...
Neurological Sciences, 1-10, 2022
182022
Influence of ApoE Genotype and Clock T3111C Interaction with Cardiovascular Risk Factors on the Progression to Alzheimer’s Disease in Subjective Cognitive …
V Bessi, J Balestrini, S Bagnoli, S Mazzeo, G Giacomucci, S Padiglioni, ...
Journal of Personalized Medicine 10 (2), 45, 2020
172020
Understanding factors associated with psychomotor subtypes of delirium in older inpatients with dementia
A Morandi, A Zambon, SG Di Santo, A Mazzone, A Cherubini, E Mossello, ...
Journal of the American Medical Directors Association 21 (4), 486-492. e7, 2020
142020
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum?
M Lassi, C Fabbiani, S Mazzeo, R Burali, AA Vergani, G Giacomucci, ...
NeuroImage: Clinical 38, 103407, 2023
122023
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia
G Giacomucci, S Mazzeo, S Bagnoli, M Casini, S Padiglioni, C Polito, ...
Journal of personalized medicine 11 (1), 47, 2021
122021
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive …
S Mazzeo, V Bessi, S Padiglioni, S Bagnoli, L Bracco, S Sorbi, B Nacmias
Neurological Sciences 40, 1559-1566, 2019
122019
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia
S Mazzeo, C Polito, S Padiglioni, V Berti, S Bagnoli, G Lombardi, I Piaceri, ...
Neurobiology of Aging 96, 155-164, 2020
112020
Acute symptomatic sinus bradycardia in high-dose methylprednisolone therapy in a woman with inflammatory myelitis: a case report and review of the literature
A Sodero, M Squitieri, S Mazzeo, M Pasca, S Matà, F Pieri, V Bessi, ...
Clinical Medicine Insights: Case Reports 12, 1179547619831026, 2019
112019
PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10‐year follow‐up study
V Bessi, G Giacomucci, S Mazzeo, S Bagnoli, S Padiglioni, J Balestrini, ...
European Journal of Neurology 28 (1), 56-65, 2021
102021
The effect of CAG repeats within the non-pathological range in the HTT gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment
V Bessi, S Mazzeo, S Bagnoli, G Giacomucci, A Ingannato, C Ferrari, ...
Diagnostics 11 (6), 1051, 2021
82021
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol
S Mazzeo, M Lassi, S Padiglioni, AA Vergani, V Moschini, M Scarpino, ...
BMC neurology 23 (1), 300, 2023
72023
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline
S Mazzeo, C Polito, M Lassi, S Bagnoli, M Mattei, S Padiglioni, V Berti, ...
Neurobiology of Aging 117, 59-70, 2022
72022
Unravelling neural correlates of empathy deficits in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease
G Giacomucci, G Galdo, C Polito, V Berti, S Padiglioni, S Mazzeo, ...
Behavioural Brain Research 428, 113893, 2022
72022
The system can't perform the operation now. Try again later.
Articles 1–20